Anticoagulation benefits patients with atrial fibrillation, intermediate stroke risk

MUNICH — In patients with atrial fibrillation and intermediate risk for stroke, direct oral anticoagulants were linked to reduced risk for death, stroke and major bleeding compared with no anticoagulation, researchers reported. The SINGLE-AF trial, conducted at 18 sites in South Korea, was presented at the European Society of Cardiology Congress and simultaneously published in The New